{"transactions":[{"id":723929,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-29T20:45:56.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying the option shall vest, and become exercisable, on the earlier of one year following the grant date or the next annual meeting of stockholders, subject to the Reporting Person's continuous service on such date."}],"balance_after":35000,"derivative":{"exercise_price":4.7,"expiration_date":"2036-06-24","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001458116-26-000002","document":"form4-06292026_080651.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000145811626000002/form4-06292026_080651.xml","form_type":"4"}},{"id":1011327,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-31T00:25:11.000Z","date":"2025-10-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":56400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of September 17, 2025, by and among 89bio, Inc. (the \"Issuer\"), Roche Holdings, Inc. (\"Parent\") and Bluefin Merger Subsidiary, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"). On October 30, 2025, Parent and Merger Sub completed a tender offer pursuant to the terms of the Merger Agreement for all outstanding shares of common stock of the Issuer (each, a \"Share\") for an offer price of (i) $14.50 per Share in cash, without interest (the \"Closing Amount\") less any required withholding taxes, plus (ii) one non-tradeable contingent value right (each, a \"CVR\") representing the right to receive certain contingent payments of up to an aggregate amount of $6.00 per Share, [continues to Footnote 2]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"[continues from Footnote 1] in cash, without interest less any required withholding taxes, upon the achievement of specified milestones on or prior to the applicable milestone outside dates, subject to and in accordance with the terms of the Contingent Value Rights Agreement (the \"CVR Agreement\"). Merger Sub thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the \"Merger\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of immediately prior to and conditioned upon the occurrence of the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, an \"Option\") became fully vested and exercisable, and to the extent not exercised prior to the effective time of the Merger, was cancelled and converted into the right to receive (i) an amount in cash (without interest and subject to deduction for any required withholding taxes) equal to the product of (A) an amount equal to the excess of the Closing Amount over the exercise price per Share with respect to such Option and (B) the number of Shares subject to such Option plus (ii) one CVR with respect to each Share subject to such Option (the \"Option Consideration\"); provided, however, that if the exercise price per Share of any Option was equal to or greater than the Closing Amount, but less than $20.50 (any such option, an \"Out of the Money Option\"), [continues to Footnote 4]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"[Continues from Footnote 3] such Out of the Money Option was not entitled to any payment of the Closing Amount in respect thereof and each Out of the Money Option was converted into the right to receive the CVR included in the Option Consideration with respect to each Share underlying such Out of the Money Option and became entitled to receive, at each time a milestone payment becomes due and payable under the terms of the CVR Agreement, an amount in cash equal to the product of (i) the number of Shares subject to such Out of the Money Option, and (ii) the amount, if any, by which (A) the Closing Amount plus the applicable milestone payment plus any other milestone payment that previously became due and payable under the terms of the CVR Agreement exceeds (B) the exercise price per Share with respect to such Out of the Money Option plus the amounts, [continues to Footnote 5]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"[Continues from Footnote 4] if any, paid to such Option holder with respect to such CVR in respect of any milestone payments that previously became due and payable under the terms of the CVR Agreement; provided further, that any Option with an exercise price that was equal to or greater than $20.50, was cancelled immediately prior to the effective time of the Merger without the receipt of any payment of the Closing Amount or CVR in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":9.6,"expiration_date":"2035-02-01","underlying":"Common Stock","underlying_shares":56400},"source":{"system":"sec-edgar","filing":"0001193125-25-259056","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000119312525259056/ownership.xml","form_type":"4"}},{"id":1011326,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-31T00:25:11.000Z","date":"2025-10-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":45150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of September 17, 2025, by and among 89bio, Inc. (the \"Issuer\"), Roche Holdings, Inc. (\"Parent\") and Bluefin Merger Subsidiary, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"). On October 30, 2025, Parent and Merger Sub completed a tender offer pursuant to the terms of the Merger Agreement for all outstanding shares of common stock of the Issuer (each, a \"Share\") for an offer price of (i) $14.50 per Share in cash, without interest (the \"Closing Amount\") less any required withholding taxes, plus (ii) one non-tradeable contingent value right (each, a \"CVR\") representing the right to receive certain contingent payments of up to an aggregate amount of $6.00 per Share, [continues to Footnote 2]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"[continues from Footnote 1] in cash, without interest less any required withholding taxes, upon the achievement of specified milestones on or prior to the applicable milestone outside dates, subject to and in accordance with the terms of the Contingent Value Rights Agreement (the \"CVR Agreement\"). Merger Sub thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the \"Merger\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of immediately prior to and conditioned upon the occurrence of the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, an \"Option\") became fully vested and exercisable, and to the extent not exercised prior to the effective time of the Merger, was cancelled and converted into the right to receive (i) an amount in cash (without interest and subject to deduction for any required withholding taxes) equal to the product of (A) an amount equal to the excess of the Closing Amount over the exercise price per Share with respect to such Option and (B) the number of Shares subject to such Option plus (ii) one CVR with respect to each Share subject to such Option (the \"Option Consideration\"); provided, however, that if the exercise price per Share of any Option was equal to or greater than the Closing Amount, but less than $20.50 (any such option, an \"Out of the Money Option\"), [continues to Footnote 4]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"[Continues from Footnote 3] such Out of the Money Option was not entitled to any payment of the Closing Amount in respect thereof and each Out of the Money Option was converted into the right to receive the CVR included in the Option Consideration with respect to each Share underlying such Out of the Money Option and became entitled to receive, at each time a milestone payment becomes due and payable under the terms of the CVR Agreement, an amount in cash equal to the product of (i) the number of Shares subject to such Out of the Money Option, and (ii) the amount, if any, by which (A) the Closing Amount plus the applicable milestone payment plus any other milestone payment that previously became due and payable under the terms of the CVR Agreement exceeds (B) the exercise price per Share with respect to such Out of the Money Option plus the amounts, [continues to Footnote 5]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"[Continues from Footnote 4] if any, paid to such Option holder with respect to such CVR in respect of any milestone payments that previously became due and payable under the terms of the CVR Agreement; provided further, that any Option with an exercise price that was equal to or greater than $20.50, was cancelled immediately prior to the effective time of the Merger without the receipt of any payment of the Closing Amount or CVR in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":9.98,"expiration_date":"2034-02-01","underlying":"Common Stock","underlying_shares":45150},"source":{"system":"sec-edgar","filing":"0001193125-25-259056","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000119312525259056/ownership.xml","form_type":"4"}},{"id":1011325,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-31T00:25:11.000Z","date":"2025-10-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":27400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of September 17, 2025, by and among 89bio, Inc. (the \"Issuer\"), Roche Holdings, Inc. (\"Parent\") and Bluefin Merger Subsidiary, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"). On October 30, 2025, Parent and Merger Sub completed a tender offer pursuant to the terms of the Merger Agreement for all outstanding shares of common stock of the Issuer (each, a \"Share\") for an offer price of (i) $14.50 per Share in cash, without interest (the \"Closing Amount\") less any required withholding taxes, plus (ii) one non-tradeable contingent value right (each, a \"CVR\") representing the right to receive certain contingent payments of up to an aggregate amount of $6.00 per Share, [continues to Footnote 2]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"[continues from Footnote 1] in cash, without interest less any required withholding taxes, upon the achievement of specified milestones on or prior to the applicable milestone outside dates, subject to and in accordance with the terms of the Contingent Value Rights Agreement (the \"CVR Agreement\"). Merger Sub thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the \"Merger\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of immediately prior to and conditioned upon the occurrence of the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, an \"Option\") became fully vested and exercisable, and to the extent not exercised prior to the effective time of the Merger, was cancelled and converted into the right to receive (i) an amount in cash (without interest and subject to deduction for any required withholding taxes) equal to the product of (A) an amount equal to the excess of the Closing Amount over the exercise price per Share with respect to such Option and (B) the number of Shares subject to such Option plus (ii) one CVR with respect to each Share subject to such Option (the \"Option Consideration\"); provided, however, that if the exercise price per Share of any Option was equal to or greater than the Closing Amount, but less than $20.50 (any such option, an \"Out of the Money Option\"), [continues to Footnote 4]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"[Continues from Footnote 3] such Out of the Money Option was not entitled to any payment of the Closing Amount in respect thereof and each Out of the Money Option was converted into the right to receive the CVR included in the Option Consideration with respect to each Share underlying such Out of the Money Option and became entitled to receive, at each time a milestone payment becomes due and payable under the terms of the CVR Agreement, an amount in cash equal to the product of (i) the number of Shares subject to such Out of the Money Option, and (ii) the amount, if any, by which (A) the Closing Amount plus the applicable milestone payment plus any other milestone payment that previously became due and payable under the terms of the CVR Agreement exceeds (B) the exercise price per Share with respect to such Out of the Money Option plus the amounts, [continues to Footnote 5]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"[Continues from Footnote 4] if any, paid to such Option holder with respect to such CVR in respect of any milestone payments that previously became due and payable under the terms of the CVR Agreement; provided further, that any Option with an exercise price that was equal to or greater than $20.50, was cancelled immediately prior to the effective time of the Merger without the receipt of any payment of the Closing Amount or CVR in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":14.7,"expiration_date":"2033-02-09","underlying":"Common Stock","underlying_shares":27400},"source":{"system":"sec-edgar","filing":"0001193125-25-259056","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000119312525259056/ownership.xml","form_type":"4"}},{"id":1011324,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-31T00:25:11.000Z","date":"2025-10-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of September 17, 2025, by and among 89bio, Inc. (the \"Issuer\"), Roche Holdings, Inc. (\"Parent\") and Bluefin Merger Subsidiary, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"). On October 30, 2025, Parent and Merger Sub completed a tender offer pursuant to the terms of the Merger Agreement for all outstanding shares of common stock of the Issuer (each, a \"Share\") for an offer price of (i) $14.50 per Share in cash, without interest (the \"Closing Amount\") less any required withholding taxes, plus (ii) one non-tradeable contingent value right (each, a \"CVR\") representing the right to receive certain contingent payments of up to an aggregate amount of $6.00 per Share, [continues to Footnote 2]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"[continues from Footnote 1] in cash, without interest less any required withholding taxes, upon the achievement of specified milestones on or prior to the applicable milestone outside dates, subject to and in accordance with the terms of the Contingent Value Rights Agreement (the \"CVR Agreement\"). Merger Sub thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the \"Merger\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of immediately prior to and conditioned upon the occurrence of the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, an \"Option\") became fully vested and exercisable, and to the extent not exercised prior to the effective time of the Merger, was cancelled and converted into the right to receive (i) an amount in cash (without interest and subject to deduction for any required withholding taxes) equal to the product of (A) an amount equal to the excess of the Closing Amount over the exercise price per Share with respect to such Option and (B) the number of Shares subject to such Option plus (ii) one CVR with respect to each Share subject to such Option (the \"Option Consideration\"); provided, however, that if the exercise price per Share of any Option was equal to or greater than the Closing Amount, but less than $20.50 (any such option, an \"Out of the Money Option\"), [continues to Footnote 4]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"[Continues from Footnote 3] such Out of the Money Option was not entitled to any payment of the Closing Amount in respect thereof and each Out of the Money Option was converted into the right to receive the CVR included in the Option Consideration with respect to each Share underlying such Out of the Money Option and became entitled to receive, at each time a milestone payment becomes due and payable under the terms of the CVR Agreement, an amount in cash equal to the product of (i) the number of Shares subject to such Out of the Money Option, and (ii) the amount, if any, by which (A) the Closing Amount plus the applicable milestone payment plus any other milestone payment that previously became due and payable under the terms of the CVR Agreement exceeds (B) the exercise price per Share with respect to such Out of the Money Option plus the amounts, [continues to Footnote 5]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"[Continues from Footnote 4] if any, paid to such Option holder with respect to such CVR in respect of any milestone payments that previously became due and payable under the terms of the CVR Agreement; provided further, that any Option with an exercise price that was equal to or greater than $20.50, was cancelled immediately prior to the effective time of the Merger without the receipt of any payment of the Closing Amount or CVR in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":2.64,"expiration_date":"2032-05-16","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001193125-25-259056","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000119312525259056/ownership.xml","form_type":"4"}},{"id":1011323,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-31T00:25:11.000Z","date":"2025-10-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of September 17, 2025, by and among 89bio, Inc. (the \"Issuer\"), Roche Holdings, Inc. (\"Parent\") and Bluefin Merger Subsidiary, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"). On October 30, 2025, Parent and Merger Sub completed a tender offer pursuant to the terms of the Merger Agreement for all outstanding shares of common stock of the Issuer (each, a \"Share\") for an offer price of (i) $14.50 per Share in cash, without interest (the \"Closing Amount\") less any required withholding taxes, plus (ii) one non-tradeable contingent value right (each, a \"CVR\") representing the right to receive certain contingent payments of up to an aggregate amount of $6.00 per Share, [continues to Footnote 2]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"[continues from Footnote 1] in cash, without interest less any required withholding taxes, upon the achievement of specified milestones on or prior to the applicable milestone outside dates, subject to and in accordance with the terms of the Contingent Value Rights Agreement (the \"CVR Agreement\"). Merger Sub thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the \"Merger\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of immediately prior to and conditioned upon the occurrence of the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, an \"Option\") became fully vested and exercisable, and to the extent not exercised prior to the effective time of the Merger, was cancelled and converted into the right to receive (i) an amount in cash (without interest and subject to deduction for any required withholding taxes) equal to the product of (A) an amount equal to the excess of the Closing Amount over the exercise price per Share with respect to such Option and (B) the number of Shares subject to such Option plus (ii) one CVR with respect to each Share subject to such Option (the \"Option Consideration\"); provided, however, that if the exercise price per Share of any Option was equal to or greater than the Closing Amount, but less than $20.50 (any such option, an \"Out of the Money Option\"), [continues to Footnote 4]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"[Continues from Footnote 3] such Out of the Money Option was not entitled to any payment of the Closing Amount in respect thereof and each Out of the Money Option was converted into the right to receive the CVR included in the Option Consideration with respect to each Share underlying such Out of the Money Option and became entitled to receive, at each time a milestone payment becomes due and payable under the terms of the CVR Agreement, an amount in cash equal to the product of (i) the number of Shares subject to such Out of the Money Option, and (ii) the amount, if any, by which (A) the Closing Amount plus the applicable milestone payment plus any other milestone payment that previously became due and payable under the terms of the CVR Agreement exceeds (B) the exercise price per Share with respect to such Out of the Money Option plus the amounts, [continues to Footnote 5]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"[Continues from Footnote 4] if any, paid to such Option holder with respect to such CVR in respect of any milestone payments that previously became due and payable under the terms of the CVR Agreement; provided further, that any Option with an exercise price that was equal to or greater than $20.50, was cancelled immediately prior to the effective time of the Merger without the receipt of any payment of the Closing Amount or CVR in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":24.16,"expiration_date":"2031-04-15","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001193125-25-259056","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000119312525259056/ownership.xml","form_type":"4"}},{"id":1011322,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-31T00:25:11.000Z","date":"2025-10-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of September 17, 2025, by and among 89bio, Inc. (the \"Issuer\"), Roche Holdings, Inc. (\"Parent\") and Bluefin Merger Subsidiary, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"). On October 30, 2025, Parent and Merger Sub completed a tender offer pursuant to the terms of the Merger Agreement for all outstanding shares of common stock of the Issuer (each, a \"Share\") for an offer price of (i) $14.50 per Share in cash, without interest (the \"Closing Amount\") less any required withholding taxes, plus (ii) one non-tradeable contingent value right (each, a \"CVR\") representing the right to receive certain contingent payments of up to an aggregate amount of $6.00 per Share, [continues to Footnote 2]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"[continues from Footnote 1] in cash, without interest less any required withholding taxes, upon the achievement of specified milestones on or prior to the applicable milestone outside dates, subject to and in accordance with the terms of the Contingent Value Rights Agreement (the \"CVR Agreement\"). Merger Sub thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the \"Merger\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of immediately prior to and conditioned upon the occurrence of the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, an \"Option\") became fully vested and exercisable, and to the extent not exercised prior to the effective time of the Merger, was cancelled and converted into the right to receive (i) an amount in cash (without interest and subject to deduction for any required withholding taxes) equal to the product of (A) an amount equal to the excess of the Closing Amount over the exercise price per Share with respect to such Option and (B) the number of Shares subject to such Option plus (ii) one CVR with respect to each Share subject to such Option (the \"Option Consideration\"); provided, however, that if the exercise price per Share of any Option was equal to or greater than the Closing Amount, but less than $20.50 (any such option, an \"Out of the Money Option\"), [continues to Footnote 4]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"[Continues from Footnote 3] such Out of the Money Option was not entitled to any payment of the Closing Amount in respect thereof and each Out of the Money Option was converted into the right to receive the CVR included in the Option Consideration with respect to each Share underlying such Out of the Money Option and became entitled to receive, at each time a milestone payment becomes due and payable under the terms of the CVR Agreement, an amount in cash equal to the product of (i) the number of Shares subject to such Out of the Money Option, and (ii) the amount, if any, by which (A) the Closing Amount plus the applicable milestone payment plus any other milestone payment that previously became due and payable under the terms of the CVR Agreement exceeds (B) the exercise price per Share with respect to such Out of the Money Option plus the amounts, [continues to Footnote 5]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"[Continues from Footnote 4] if any, paid to such Option holder with respect to such CVR in respect of any milestone payments that previously became due and payable under the terms of the CVR Agreement; provided further, that any Option with an exercise price that was equal to or greater than $20.50, was cancelled immediately prior to the effective time of the Merger without the receipt of any payment of the Closing Amount or CVR in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":24.29,"expiration_date":"2030-06-22","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001193125-25-259056","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000119312525259056/ownership.xml","form_type":"4"}},{"id":1011321,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-31T00:25:11.000Z","date":"2025-10-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of September 17, 2025, by and among 89bio, Inc. (the \"Issuer\"), Roche Holdings, Inc. (\"Parent\") and Bluefin Merger Subsidiary, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"). On October 30, 2025, Parent and Merger Sub completed a tender offer pursuant to the terms of the Merger Agreement for all outstanding shares of common stock of the Issuer (each, a \"Share\") for an offer price of (i) $14.50 per Share in cash, without interest (the \"Closing Amount\") less any required withholding taxes, plus (ii) one non-tradeable contingent value right (each, a \"CVR\") representing the right to receive certain contingent payments of up to an aggregate amount of $6.00 per Share, [continues to Footnote 2]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"[continues from Footnote 1] in cash, without interest less any required withholding taxes, upon the achievement of specified milestones on or prior to the applicable milestone outside dates, subject to and in accordance with the terms of the Contingent Value Rights Agreement (the \"CVR Agreement\"). Merger Sub thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the \"Merger\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of immediately prior to and conditioned upon the occurrence of the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, an \"Option\") became fully vested and exercisable, and to the extent not exercised prior to the effective time of the Merger, was cancelled and converted into the right to receive (i) an amount in cash (without interest and subject to deduction for any required withholding taxes) equal to the product of (A) an amount equal to the excess of the Closing Amount over the exercise price per Share with respect to such Option and (B) the number of Shares subject to such Option plus (ii) one CVR with respect to each Share subject to such Option (the \"Option Consideration\"); provided, however, that if the exercise price per Share of any Option was equal to or greater than the Closing Amount, but less than $20.50 (any such option, an \"Out of the Money Option\"), [continues to Footnote 4]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"[Continues from Footnote 3] such Out of the Money Option was not entitled to any payment of the Closing Amount in respect thereof and each Out of the Money Option was converted into the right to receive the CVR included in the Option Consideration with respect to each Share underlying such Out of the Money Option and became entitled to receive, at each time a milestone payment becomes due and payable under the terms of the CVR Agreement, an amount in cash equal to the product of (i) the number of Shares subject to such Out of the Money Option, and (ii) the amount, if any, by which (A) the Closing Amount plus the applicable milestone payment plus any other milestone payment that previously became due and payable under the terms of the CVR Agreement exceeds (B) the exercise price per Share with respect to such Out of the Money Option plus the amounts, [continues to Footnote 5]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"[Continues from Footnote 4] if any, paid to such Option holder with respect to such CVR in respect of any milestone payments that previously became due and payable under the terms of the CVR Agreement; provided further, that any Option with an exercise price that was equal to or greater than $20.50, was cancelled immediately prior to the effective time of the Merger without the receipt of any payment of the Closing Amount or CVR in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":23.22,"expiration_date":"2030-03-23","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001193125-25-259056","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000119312525259056/ownership.xml","form_type":"4"}},{"id":1099217,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-30T21:00:08.000Z","date":"2025-06-26","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying the option shall vest, and become exercisable, on the earlier of June 26, 2026, or the date of the Issuer's next annual stockholders meeting, subject to the Reporting Person's continuous service on such date."}],"balance_after":25000,"derivative":{"exercise_price":4.18,"expiration_date":"2035-06-25","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-25-018519","document":"form4-06302025_050604.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000141588925018519/form4-06302025_050604.xml","form_type":"4"}},{"id":1101396,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Unit","published_at":"2025-06-26T20:56:45.000Z","date":"2025-06-24","kind":"exercise","planned":false,"acquired":false,"shares":40486,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 6, 2025, the Issuer and its subsidiaries (collectively, the \"Debtors\") filed voluntary petitions for relief under chapter 11 of title 11 of the United States Code in the United States Bankruptcy Court for the District of Delaware (the \"Chapter 11 Cases,\" and such court, the \"Bankruptcy Court\"). On June 17, 2025, the Bankruptcy Court entered an order (the \"Confirmation Order\") confirming the Debtors' First Amended Joint Prepackaged Plan of Reorganization, as modified by the Confirmation Order (the \"Plan\"). On June 24, 2025 (the \"Effective Date\"), the Plan became effective in accordance with its terms and the Debtors emerged from the Chapter 11 Cases."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Deferred Stock Unit represents a right to receive one share of Old Common Stock upon settlement (as defined below)."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 6, 2025, the Issuer and its subsidiaries (collectively, the \"Debtors\") filed voluntary petitions for relief under chapter 11 of title 11 of the United States Code in the United States Bankruptcy Court for the District of Delaware (the \"Chapter 11 Cases,\" and such court, the \"Bankruptcy Court\"). On June 17, 2025, the Bankruptcy Court entered an order (the \"Confirmation Order\") confirming the Debtors' First Amended Joint Prepackaged Plan of Reorganization, as modified by the Confirmation Order (the \"Plan\"). On June 24, 2025 (the \"Effective Date\"), the Plan became effective in accordance with its terms and the Debtors emerged from the Chapter 11 Cases."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Plan and upon the Reporting Person ceasing to be a member of the Board of Directors, each Deferred Stock Unit settled in full."},{"field":"shares","element":"transactionShares","label":"F1","text":"On May 6, 2025, the Issuer and its subsidiaries (collectively, the \"Debtors\") filed voluntary petitions for relief under chapter 11 of title 11 of the United States Code in the United States Bankruptcy Court for the District of Delaware (the \"Chapter 11 Cases,\" and such court, the \"Bankruptcy Court\"). On June 17, 2025, the Bankruptcy Court entered an order (the \"Confirmation Order\") confirming the Debtors' First Amended Joint Prepackaged Plan of Reorganization, as modified by the Confirmation Order (the \"Plan\"). On June 24, 2025 (the \"Effective Date\"), the Plan became effective in accordance with its terms and the Debtors emerged from the Chapter 11 Cases."},{"field":"shares","element":"transactionShares","label":"F2","text":"Pursuant to the Plan and upon the Reporting Person ceasing to be a member of the Board of Directors, each Deferred Stock Unit settled in full."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 6, 2025, the Issuer and its subsidiaries (collectively, the \"Debtors\") filed voluntary petitions for relief under chapter 11 of title 11 of the United States Code in the United States Bankruptcy Court for the District of Delaware (the \"Chapter 11 Cases,\" and such court, the \"Bankruptcy Court\"). On June 17, 2025, the Bankruptcy Court entered an order (the \"Confirmation Order\") confirming the Debtors' First Amended Joint Prepackaged Plan of Reorganization, as modified by the Confirmation Order (the \"Plan\"). On June 24, 2025 (the \"Effective Date\"), the Plan became effective in accordance with its terms and the Debtors emerged from the Chapter 11 Cases."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Plan and upon the Reporting Person ceasing to be a member of the Board of Directors, each Deferred Stock Unit settled in full."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Plan and upon the Reporting Person ceasing to be a member of the Board of Directors, each Deferred Stock Unit settled in full."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Plan and upon the Reporting Person ceasing to be a member of the Board of Directors, each Deferred Stock Unit settled in full."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":40486},"source":{"system":"sec-edgar","filing":"0000950170-25-090483","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/105319/000095017025090483/ownership.xml","form_type":"4"}},{"id":1101395,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-26T20:56:45.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":735,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Pursuant to the Plan, on the Effective Date, all outstanding shares of the Issuer's common stock (the \"Old Common Stock\") were cancelled and extinguished. Pursuant to the Plan, new shares of the Issuer's common stock, no par value (the \"New Common Stock\") were issued to the Reporting Person on a ratio of 1 share of New Common Stock for approximately every 93 shares of Old Common Stock held by the Reporting Person on the Effective Date. The receipt of shares of New Common Stock was involuntary, without consideration and in accordance with the Plan approved by the Bankruptcy Court."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Plan, on the Effective Date, all outstanding shares of the Issuer's common stock (the \"Old Common Stock\") were cancelled and extinguished. Pursuant to the Plan, new shares of the Issuer's common stock, no par value (the \"New Common Stock\") were issued to the Reporting Person on a ratio of 1 share of New Common Stock for approximately every 93 shares of Old Common Stock held by the Reporting Person on the Effective Date. The receipt of shares of New Common Stock was involuntary, without consideration and in accordance with the Plan approved by the Bankruptcy Court."}],"balance_after":735,"source":{"system":"sec-edgar","filing":"0000950170-25-090483","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/105319/000095017025090483/ownership.xml","form_type":"4"}},{"id":1101394,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-26T20:56:45.000Z","date":"2025-06-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":68399,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Pursuant to the Plan, on the Effective Date, all outstanding shares of the Issuer's common stock (the \"Old Common Stock\") were cancelled and extinguished. Pursuant to the Plan, new shares of the Issuer's common stock, no par value (the \"New Common Stock\") were issued to the Reporting Person on a ratio of 1 share of New Common Stock for approximately every 93 shares of Old Common Stock held by the Reporting Person on the Effective Date. The receipt of shares of New Common Stock was involuntary, without consideration and in accordance with the Plan approved by the Bankruptcy Court."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Plan, on the Effective Date, all outstanding shares of the Issuer's common stock (the \"Old Common Stock\") were cancelled and extinguished. Pursuant to the Plan, new shares of the Issuer's common stock, no par value (the \"New Common Stock\") were issued to the Reporting Person on a ratio of 1 share of New Common Stock for approximately every 93 shares of Old Common Stock held by the Reporting Person on the Effective Date. The receipt of shares of New Common Stock was involuntary, without consideration and in accordance with the Plan approved by the Bankruptcy Court."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-090483","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105319/000095017025090483/ownership.xml","form_type":"4"}},{"id":1101393,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-26T20:56:45.000Z","date":"2025-06-24","kind":"exercise","planned":false,"acquired":true,"shares":40486,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 6, 2025, the Issuer and its subsidiaries (collectively, the \"Debtors\") filed voluntary petitions for relief under chapter 11 of title 11 of the United States Code in the United States Bankruptcy Court for the District of Delaware (the \"Chapter 11 Cases,\" and such court, the \"Bankruptcy Court\"). On June 17, 2025, the Bankruptcy Court entered an order (the \"Confirmation Order\") confirming the Debtors' First Amended Joint Prepackaged Plan of Reorganization, as modified by the Confirmation Order (the \"Plan\"). On June 24, 2025 (the \"Effective Date\"), the Plan became effective in accordance with its terms and the Debtors emerged from the Chapter 11 Cases."},{"field":"shares","element":"transactionShares","label":"F2","text":"Pursuant to the Plan and upon the Reporting Person ceasing to be a member of the Board of Directors, each Deferred Stock Unit settled in full."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 6, 2025, the Issuer and its subsidiaries (collectively, the \"Debtors\") filed voluntary petitions for relief under chapter 11 of title 11 of the United States Code in the United States Bankruptcy Court for the District of Delaware (the \"Chapter 11 Cases,\" and such court, the \"Bankruptcy Court\"). On June 17, 2025, the Bankruptcy Court entered an order (the \"Confirmation Order\") confirming the Debtors' First Amended Joint Prepackaged Plan of Reorganization, as modified by the Confirmation Order (the \"Plan\"). On June 24, 2025 (the \"Effective Date\"), the Plan became effective in accordance with its terms and the Debtors emerged from the Chapter 11 Cases."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Plan and upon the Reporting Person ceasing to be a member of the Board of Directors, each Deferred Stock Unit settled in full."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each Deferred Stock Unit represents a right to receive one share of Old Common Stock upon settlement (as defined below)."}],"balance_after":68399,"source":{"system":"sec-edgar","filing":"0000950170-25-090483","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000095017025090483/ownership.xml","form_type":"4"}},{"id":1281718,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-05T21:01:06.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":56400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 56,400 shares of the Issuer's Common Stock, which will vest in full on February 1, 2026, subject to the Reporting Person's continued service to the Issuer through such date."}],"balance_after":56400,"derivative":{"exercise_price":9.6,"expiration_date":"2035-02-03","underlying":"Common Stock","underlying_shares":56400},"source":{"system":"sec-edgar","filing":"0000950170-25-014433","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000095017025014433/ownership.xml","form_type":"4"}},{"id":1319375,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Unit","published_at":"2025-01-02T21:01:08.000Z","date":"2024-12-30","kind":"grant","planned":false,"acquired":true,"shares":3696,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Stock Unit represents a right to receive one share of Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock (i) for 14,784 shares, on the earlier of August 15, 2034 (at which time, such shares of Common Stock will be subject to transfer restrictions) and the date of the Reporting Person's separation from service from the Issuer's Board of Directors (the \"Separation Date\") and (ii) for 25,702 shares, on the Separation Date, all pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock (i) for 14,784 shares, on the earlier of August 15, 2034 (at which time, such shares of Common Stock will be subject to transfer restrictions) and the date of the Reporting Person's separation from service from the Issuer's Board of Directors (the \"Separation Date\") and (ii) for 25,702 shares, on the Separation Date, all pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors."}],"balance_after":40486,"derivative":{"underlying":"Common Stock","underlying_shares":3696},"source":{"system":"sec-edgar","filing":"0000950170-25-000389","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000095017025000389/ownership.xml","form_type":"4"}},{"id":1395829,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Unit","published_at":"2024-10-02T20:01:10.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":3696,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Stock Unit represents a right to receive one share of Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock (i) for 11,088 shares, on the earlier of August 15, 2034 (at which time, such shares of Common Stock will be subject to transfer restrictions) and the date of the Reporting Person's separation from service from the Issuer's Board of Directors (the \"Separation Date\") and (ii) for 25,702 shares, on the Separation Date, all pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock (i) for 11,088 shares, on the earlier of August 15, 2034 (at which time, such shares of Common Stock will be subject to transfer restrictions) and the date of the Reporting Person's separation from service from the Issuer's Board of Directors (the \"Separation Date\") and (ii) for 25,702 shares, on the Separation Date, all pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors."}],"balance_after":36790,"derivative":{"underlying":"Common Stock","underlying_shares":3696},"source":{"system":"sec-edgar","filing":"0000950170-24-111403","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000095017024111403/ownership.xml","form_type":"4"}},{"id":1461613,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Unit","published_at":"2024-07-03T20:32:44.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":3696,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Stock Unit represents a right to receive one share of Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock (i) for 7,392 shares, on the earlier of August 15, 2034 (at which time, such shares of Common Stock will be subject to transfer restrictions) and the date of the Reporting Person's separation from service from the Issuer's Board of Directors (the \"Separation Date\") and (ii) for 25,702 shares, on the Separation Date, all pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock (i) for 7,392 shares, on the earlier of August 15, 2034 (at which time, such shares of Common Stock will be subject to transfer restrictions) and the date of the Reporting Person's separation from service from the Issuer's Board of Directors (the \"Separation Date\") and (ii) for 25,702 shares, on the Separation Date, all pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors."}],"balance_after":33094,"derivative":{"underlying":"Common Stock","underlying_shares":3696},"source":{"system":"sec-edgar","filing":"0000950170-24-081572","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000095017024081572/ownership.xml","form_type":"4"}},{"id":1468070,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-27T21:04:37.000Z","date":"2024-06-25","kind":"grant","planned":false,"acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying the option shall vest, and become exercisable, on the earlier of June 25, 2025, or the date of the Issuer's next annual stockholders meeting, subject to the Reporting Person's continuous service on such date."}],"balance_after":18000,"derivative":{"exercise_price":16.87,"expiration_date":"2034-06-24","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001415889-24-018348","document":"form4-06272024_090634.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000141588924018348/form4-06272024_090634.xml","form_type":"4"}},{"id":1552032,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Unit","published_at":"2024-04-03T20:31:46.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":3696,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Stock Unit represents a right to receive one share of Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock (i) for 3,696 shares, on the earlier of August 15, 2034 (at which time, such shares of Common Stock will be subject to transfer restrictions) and the date of the Reporting Person's separation from service from the Issuer's Board of Directors (the \"Separation Date\") and (ii) for 25,702 shares, on the Separation Date, all pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock (i) for 3,696 shares, on the earlier of August 15, 2034 (at which time, such shares of Common Stock will be subject to transfer restrictions) and the date of the Reporting Person's separation from service from the Issuer's Board of Directors (the \"Separation Date\") and (ii) for 25,702 shares, on the Separation Date, all pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors."}],"balance_after":29398,"derivative":{"underlying":"Common Stock","underlying_shares":3696},"source":{"system":"sec-edgar","filing":"0000950170-24-041132","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000095017024041132/ownership.xml","form_type":"4"}},{"id":1658671,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-06T01:08:49.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":45150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 45,150 shares of the Issuer's Common Stock, which will vest in full on February 1, 2025, subject to the Reporting Person's continued service to the Issuer through such date."}],"balance_after":45150,"derivative":{"exercise_price":9.98,"expiration_date":"2034-02-01","underlying":"Common Stock","underlying_shares":45150},"source":{"system":"sec-edgar","filing":"0000950170-24-011462","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000095017024011462/ownership.xml","form_type":"4"}},{"id":1671982,"issuer":{"id":94933,"kind":"organization","name":"Orchard Therapeutics plc","symbol":"ORTX"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-24T22:16:40.000Z","date":"2024-01-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 24, 2024, Kyowa Kirin Co., Ltd., a Japanese joint stock company (\"KKC\") acquired all outstanding ordinary shares, nominal value GBP 0.10 per share (the \"Ordinary Shares\") of Orchard Therapeutics plc, a public limited company incorporated in England and Wales (the \"Company\"), by means of a scheme of arrangement under Part 26 of the UK Companies Act 2006. The transaction is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on November 16, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Transaction Agreement dated as of October 5, 2023 by and between KKC and the Company, these options were cancelled in exchange for (i) an amount in cash equal to the excess of the Cash Consideration ($1.60 per share) over the per share exercise price of such options, and (ii) one contractual contingent value right (each, a \"CVR\"), each representing the right to receive a contingent payment of $0.10 in cash, without interest, if a certain milestone is achieved, pursuant to the Contingent Value Rights Agreement between KKC and a rights agent mutually agreeable to the Company and KKC."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents ten Ordinary Shares."}],"balance_after":0,"derivative":{"exercise_price":0.495,"expiration_date":"2033-06-13","underlying":"Ordinary Shares","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0000950170-24-007054","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000095017024007054/ownership.xml","form_type":"4"}},{"id":1671981,"issuer":{"id":94933,"kind":"organization","name":"Orchard Therapeutics plc","symbol":"ORTX"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-24T22:16:40.000Z","date":"2024-01-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":46000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 24, 2024, Kyowa Kirin Co., Ltd., a Japanese joint stock company (\"KKC\") acquired all outstanding ordinary shares, nominal value GBP 0.10 per share (the \"Ordinary Shares\") of Orchard Therapeutics plc, a public limited company incorporated in England and Wales (the \"Company\"), by means of a scheme of arrangement under Part 26 of the UK Companies Act 2006. The transaction is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on November 16, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Transaction Agreement dated as of October 5, 2023 by and between KKC and the Company, these options were cancelled in exchange for (i) an amount in cash equal to the excess of the Cash Consideration ($1.60 per share) over the per share exercise price of such options, and (ii) one contractual contingent value right (each, a \"CVR\"), each representing the right to receive a contingent payment of $0.10 in cash, without interest, if a certain milestone is achieved, pursuant to the Contingent Value Rights Agreement between KKC and a rights agent mutually agreeable to the Company and KKC."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents ten Ordinary Shares."}],"balance_after":0,"derivative":{"exercise_price":0.475,"expiration_date":"2032-06-06","underlying":"Ordinary Shares","underlying_shares":46000},"source":{"system":"sec-edgar","filing":"0000950170-24-007054","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000095017024007054/ownership.xml","form_type":"4"}},{"id":1695369,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Unit","published_at":"2024-01-03T21:20:08.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":3696,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Stock Unit represents a right to receive one share of Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors."}],"balance_after":25702,"derivative":{"underlying":"Common Stock","underlying_shares":3696},"source":{"system":"sec-edgar","filing":"0000950170-24-000918","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000095017024000918/ownership.xml","form_type":"4"}},{"id":1766191,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Unit","published_at":"2023-10-04T20:26:24.000Z","date":"2023-10-02","kind":"grant","planned":false,"acquired":true,"shares":3696,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Stock Unit represents a right to receive one share of Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors."}],"balance_after":22006,"derivative":{"underlying":"Common Stock","underlying_shares":3696},"source":{"system":"sec-edgar","filing":"0001209191-23-051962","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919123051962/doc4.xml","form_type":"4"}},{"id":1838648,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Unit","published_at":"2023-07-05T20:23:43.000Z","date":"2023-07-03","kind":"grant","planned":false,"acquired":true,"shares":2053,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Stock Unit represents a right to receive one share of Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors."}],"balance_after":18310,"derivative":{"underlying":"Common Stock","underlying_shares":2053},"source":{"system":"sec-edgar","filing":"0001209191-23-041064","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919123041064/doc4.xml","form_type":"4"}},{"id":1852023,"issuer":{"id":94933,"kind":"organization","name":"Orchard Therapeutics plc","symbol":"ORTX"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T20:30:21.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the shares subject to this option vest upon the earlier to occur of June 14, 2024 or the date of the 2024 Annual General Meeting of the Company."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents ten Ordinary Shares."}],"balance_after":105000,"derivative":{"exercise_price":0.495,"expiration_date":"2033-06-13","underlying":"Ordinary Shares","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0001209191-23-037908","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000120919123037908/doc4.xml","form_type":"4"}},{"id":1926136,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Unit","published_at":"2023-04-05T20:03:49.000Z","date":"2023-04-03","kind":"grant","planned":false,"acquired":true,"shares":2053,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Stock Unit represents a right to receive one share of Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors."}],"balance_after":16257,"derivative":{"underlying":"Common Stock","underlying_shares":2053},"source":{"system":"sec-edgar","filing":"0001209191-23-023252","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919123023252/doc4.xml","form_type":"4"}},{"id":2019872,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-13T22:48:01.000Z","date":"2023-02-09","kind":"grant","acquired":true,"shares":27400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 27,400 shares of the Issuer's Common Stock, which will vest in full on February 9, 2024, subject to the Reporting Person's continued service to the Issuer through such date."}],"balance_after":27400,"derivative":{"exercise_price":14.7,"expiration_date":"2033-02-09","underlying":"Common Stock","underlying_shares":27400},"source":{"system":"sec-edgar","filing":"0000899243-23-004826","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000089924323004826/doc4.xml","form_type":"4"}},{"id":2071192,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Unit","published_at":"2023-01-04T21:19:06.000Z","date":"2023-01-02","kind":"grant","acquired":true,"shares":5067,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Stock Unit represents a right to receive one share of Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors."}],"balance_after":14204,"derivative":{"underlying":"Common Stock","underlying_shares":5067},"source":{"system":"sec-edgar","filing":"0001209191-23-000900","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919123000900/doc4.xml","form_type":"4"}},{"id":2143235,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Unit","published_at":"2022-10-05T21:24:01.000Z","date":"2022-10-03","kind":"grant","acquired":true,"shares":4595,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Stock Unit represents a right to receive one share of Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors."}],"balance_after":9137,"derivative":{"underlying":"Common Stock","underlying_shares":4595},"source":{"system":"sec-edgar","filing":"0001209191-22-052824","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919122052824/doc4.xml","form_type":"4"}},{"id":2213466,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Unit","published_at":"2022-07-06T20:27:20.000Z","date":"2022-07-04","kind":"grant","acquired":true,"shares":2745,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Stock Unit represents a right to receive one share of Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors."}],"balance_after":4542,"derivative":{"underlying":"Common Stock","underlying_shares":2745},"source":{"system":"sec-edgar","filing":"0001209191-22-041120","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919122041120/doc4.xml","form_type":"4"}},{"id":2239028,"issuer":{"id":94933,"kind":"organization","name":"Orchard Therapeutics plc","symbol":"ORTX"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-08T20:05:47.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":46000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the shares subject to this option vest upon the earlier to occur of June 7, 2023 or the date of the 2023 Annual General Meeting of the Company."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":46000,"derivative":{"exercise_price":0.4747,"expiration_date":"2032-06-06","underlying":"Ordinary Shares","underlying_shares":46000},"source":{"system":"sec-edgar","filing":"0001209191-22-035003","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000120919122035003/doc4.xml","form_type":"4"}},{"id":2265583,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-18T20:05:24.000Z","date":"2022-05-16","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 25,000 shares of the Issuer's Common Stock, which will vest in full on May 16, 2023, subject to the Reporting Person's continued service to the Issuer through such date."}],"balance_after":25000,"derivative":{"exercise_price":2.64,"expiration_date":"2032-05-16","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-22-018586","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000089924322018586/doc4.xml","form_type":"4"}},{"id":2303128,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Unit","published_at":"2022-04-06T20:14:44.000Z","date":"2022-04-04","kind":"grant","acquired":true,"shares":1797,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Stock Unit represents a right to receive one share of Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors."}],"balance_after":1797,"derivative":{"underlying":"Common Stock","underlying_shares":1797},"source":{"system":"sec-edgar","filing":"0001209191-22-023461","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919122023461/doc4.xml","form_type":"4"}},{"id":2446348,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T21:14:07.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":1179,"price":15.9,"value":18746.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":27913,"source":{"system":"sec-edgar","filing":"0001209191-22-001646","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919122001646/doc4.xml","form_type":"4"}},{"id":2547646,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-06T20:08:43.000Z","date":"2021-10-04","kind":"grant","acquired":true,"shares":998,"price":18.78,"value":18742.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":26734,"source":{"system":"sec-edgar","filing":"0001209191-21-059808","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919121059808/doc4.xml","form_type":"4"}},{"id":2640190,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-07T20:22:16.000Z","date":"2021-07-05","kind":"grant","acquired":true,"shares":523,"price":35.84,"value":18744.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":25736,"source":{"system":"sec-edgar","filing":"0001209191-21-045788","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919121045788/doc4.xml","form_type":"4"}},{"id":2663586,"issuer":{"id":94933,"kind":"organization","name":"Orchard Therapeutics plc","symbol":"ORTX"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T21:02:03.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the shares subject to this option vest upon the earlier to occur of June 16, 2022 or the date of the 2022 Annual General Meeting of the Company."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":40000,"derivative":{"exercise_price":4.79,"expiration_date":"2031-06-15","underlying":"Ordinary Shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-21-041505","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000120919121041505/doc4.xml","form_type":"4"}},{"id":2745039,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-19T20:45:47.000Z","date":"2021-04-15","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 12,500 shares of the Issuer's Common Stock, one third of which will vest on April 15, 2022, with the remaining two thirds vesting in equal monthly installments over the following two years, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":12500,"derivative":{"exercise_price":24.16,"expiration_date":"2031-04-15","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000899243-21-016224","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000089924321016224/doc4.xml","form_type":"4"}},{"id":2755020,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-07T20:21:53.000Z","date":"2021-04-05","kind":"grant","acquired":true,"shares":609,"price":30.77,"value":18738.93,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":25213,"source":{"system":"sec-edgar","filing":"0001209191-21-025867","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919121025867/doc4.xml","form_type":"4"}},{"id":3083545,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-14T21:01:26.000Z","date":"2020-06-22","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 7,000 shares of the Issuer's Common Stock, which will vest in full on June 22, 2021, subject to the Reporting Person's continued service to the Issuer through such date."}],"balance_after":7000,"derivative":{"exercise_price":24.29,"expiration_date":"2030-06-22","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0000899243-20-019090","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000089924320019090/doc4.xml","form_type":"4"}},{"id":3095972,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-01T20:10:54.000Z","date":"2020-06-29","kind":"grant","acquired":true,"shares":521,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":24604,"source":{"system":"sec-edgar","filing":"0001209191-20-039715","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919120039715/doc4.xml","form_type":"4"}},{"id":3104246,"issuer":{"id":94933,"kind":"organization","name":"Orchard Therapeutics plc","symbol":"ORTX"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-19T20:06:53.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the shares subject to this option vest upon the earlier to occur of June 17, 2021 or the date of the 2021 Annual General Meeting of the Company."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":35000,"derivative":{"exercise_price":7.81,"expiration_date":"2030-06-16","underlying":"Ordinary Shares","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-20-037901","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000120919120037901/doc4.xml","form_type":"4"}},{"id":3190112,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-01T20:11:36.000Z","date":"2020-03-30","kind":"grant","acquired":true,"shares":1128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":24083,"source":{"system":"sec-edgar","filing":"0001209191-20-022095","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919120022095/doc4.xml","form_type":"4"}},{"id":3195258,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-26T01:15:16.000Z","date":"2020-03-23","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 40,000 shares of the Issuer's Common Stock, which will vest in equal installments on the first, second and third anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":40000,"derivative":{"exercise_price":23.22,"expiration_date":"2030-03-23","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000899243-20-009444","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000089924320009444/doc4.xml","form_type":"4"}},{"id":3294849,"issuer":{"id":94933,"kind":"organization","name":"Orchard Therapeutics plc","symbol":"ORTX"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-04T01:56:42.000Z","date":"2020-02-03","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vest in equal monthly installments over the three years after February 3, 2020."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":50000,"derivative":{"exercise_price":12.3,"expiration_date":"2030-02-02","underlying":"Ordinary Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-20-006159","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000120919120006159/doc4.xml","form_type":"4"}},{"id":3328337,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-02T21:10:17.000Z","date":"2019-12-30","kind":"grant","acquired":true,"shares":469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":22955,"source":{"system":"sec-edgar","filing":"0001209191-20-000246","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919120000246/doc4.xml","form_type":"4"}},{"id":3338831,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-17T21:30:53.000Z","date":"2019-12-17","kind":"disposition_to_issuer","acquired":false,"shares":37203,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, each outstanding Spark stock option, whether vested or unvested, was converted into the right to an amount in cash (less applicable tax withholdings) equal to the product of (a) the excess of $114.50 over the per share exercise price of such stock option and (b) the total number of shares of common stock subject to such stock option."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The reporting person was formerly the Chief Executive Officer of The Children's Hospital of Philadelphia Foundation (\"CHOP Foundation\"), and he held this option for the benefit of CHOP Foundation."}],"balance_after":0,"derivative":{"exercise_price":3.45,"expiration_date":"2024-08-11","underlying":"Common Stock","underlying_shares":37203},"source":{"system":"sec-edgar","filing":"0000899243-19-029419","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000089924319029419/doc4.xml","form_type":"4"}},{"id":3338830,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-17T21:30:53.000Z","date":"2019-12-17","kind":"disposition_to_issuer","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, each outstanding Spark stock option, whether vested or unvested, was converted into the right to an amount in cash (less applicable tax withholdings) equal to the product of (a) the excess of $114.50 over the per share exercise price of such stock option and (b) the total number of shares of common stock subject to such stock option."}],"balance_after":0,"derivative":{"exercise_price":56.22,"expiration_date":"2026-05-31","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0000899243-19-029419","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000089924319029419/doc4.xml","form_type":"4"}},{"id":3338829,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-17T21:30:53.000Z","date":"2019-12-17","kind":"disposition_to_issuer","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, each outstanding Spark stock option, whether vested or unvested, was converted into the right to an amount in cash (less applicable tax withholdings) equal to the product of (a) the excess of $114.50 over the per share exercise price of such stock option and (b) the total number of shares of common stock subject to such stock option."}],"balance_after":0,"derivative":{"exercise_price":50.93,"expiration_date":"2027-05-30","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0000899243-19-029419","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000089924319029419/doc4.xml","form_type":"4"}},{"id":3338828,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-17T21:30:53.000Z","date":"2019-12-17","kind":"disposition_to_issuer","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, each outstanding Spark stock option, whether vested or unvested, was converted into the right to an amount in cash (less applicable tax withholdings) equal to the product of (a) the excess of $114.50 over the per share exercise price of such stock option and (b) the total number of shares of common stock subject to such stock option."}],"balance_after":0,"derivative":{"exercise_price":81.53,"expiration_date":"2028-05-29","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0000899243-19-029419","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000089924319029419/doc4.xml","form_type":"4"}},{"id":3338827,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-17T21:30:53.000Z","date":"2019-12-17","kind":"other","acquired":false,"shares":28000,"price":114.5,"value":3206000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger, dated February 22, 2019, by and between Spark Therapeutics, Inc. (\"Spark\"), Roche Holdings, Inc. (\"Roche\") and 022019 Merger Subsidiary, Inc. (\"Merger Sub\") (the \"Merger Agreement\" and the transactions contemplated thereby, the \"Merger\"), whereby Roche caused Merger Sub to conduct a tender offer for all of the issued and outstanding shares of common stock, par value $0.001 per share, of Spark, at a price of $114.50 per share. On December 17, 2019, Merger Sub irrevocably accepted for payment all shares that were validly tendered and not withdrawn."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-19-029419","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000089924319029419/doc4.xml","form_type":"4"}},{"id":3378234,"issuer":{"id":3964,"kind":"organization","name":"Covista Inc.","symbol":"CVSA"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-11-07T19:01:15.000Z","date":"2019-11-06","kind":"grant","acquired":true,"shares":3940,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the satisfaction of tax withholding obligations upon the vesting of previously awarded restricted stock units."}],"balance_after":6170,"source":{"system":"sec-edgar","filing":"0001127602-19-032132","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730464/000112760219032132/form4.xml","form_type":"4"}},{"id":3402143,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-02T20:57:41.000Z","date":"2019-09-30","kind":"grant","acquired":true,"shares":514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":22486,"source":{"system":"sec-edgar","filing":"0001209191-19-051792","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919119051792/doc4.xml","form_type":"4"}},{"id":3473512,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-02T20:07:15.000Z","date":"2019-07-01","kind":"grant","acquired":true,"shares":989,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":21972,"source":{"system":"sec-edgar","filing":"0001209191-19-040185","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919119040185/doc4.xml","form_type":"4"}},{"id":3504635,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-06-03T20:16:40.000Z","date":"2019-05-30","kind":"exercise","acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Spark Therapeutics, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On May 30, 2018, the reporting person was granted 1,500 restricted stock units that vest on the one-year anniversary of the grant date.  Vested shares are delivered to the reporting person on the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On May 30, 2018, the reporting person was granted 1,500 restricted stock units that vest on the one-year anniversary of the grant date.  Vested shares are delivered to the reporting person on the vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001609351-19-000055","document":"wf-form4_155959298469415.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000160935119000055/wf-form4_155959298469415.xml","form_type":"4"}},{"id":3504634,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-03T20:16:40.000Z","date":"2019-05-30","kind":"exercise","acquired":true,"shares":1500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit converted into one share of Spark Therapeutics, Inc. common stock."}],"balance_after":28000,"source":{"system":"sec-edgar","filing":"0001609351-19-000055","document":"wf-form4_155959298469415.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000160935119000055/wf-form4_155959298469415.xml","form_type":"4"}},{"id":3567004,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-03T20:29:05.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":942,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":20983,"source":{"system":"sec-edgar","filing":"0001209191-19-023131","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919119023131/doc4.xml","form_type":"4"}},{"id":3706569,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-04T21:09:16.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":453,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":20041,"source":{"system":"sec-edgar","filing":"0001209191-19-001883","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919119001883/doc4.xml","form_type":"4"}},{"id":3771126,"issuer":{"id":3964,"kind":"organization","name":"Covista Inc.","symbol":"CVSA"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-11-08T21:32:27.000Z","date":"2018-11-06","kind":"grant","acquired":true,"shares":2230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The common stock is a restricted stock unit which represents a right to receive one share of common stock for each restricted stock unit.  Stock units vest 100% on the one year anniversary of the transaction date."}],"balance_after":2230,"source":{"system":"sec-edgar","filing":"0001127602-18-032520","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730464/000112760218032520/form4.xml","form_type":"4"}},{"id":3799999,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-03T20:10:00.000Z","date":"2018-10-01","kind":"grant","acquired":true,"shares":262,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":19588,"source":{"system":"sec-edgar","filing":"0001209191-18-053768","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919118053768/doc4.xml","form_type":"4"}},{"id":3873597,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-05T20:13:24.000Z","date":"2018-07-02","kind":"grant","acquired":true,"shares":187,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":19326,"source":{"system":"sec-edgar","filing":"0001209191-18-041571","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919118041571/doc4.xml","form_type":"4"}},{"id":3912401,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-06-01T01:29:03.000Z","date":"2018-05-31","kind":"exercise","acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Spark Therapeutics, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On May 31, 2017, the reporting person was granted 1,500 restricted stock units that vest on the one-year anniversary of the grant date.  Vested shares are delivered to the reporting person on the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On May 31, 2017, the reporting person was granted 1,500 restricted stock units that vest on the one-year anniversary of the grant date.  Vested shares are delivered to the reporting person on the vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001609351-18-000054","document":"wf-form4_152781652931863.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000160935118000054/wf-form4_152781652931863.xml","form_type":"4"}},{"id":3912400,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-06-01T01:29:03.000Z","date":"2018-05-30","kind":"grant","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Spark Therapeutics, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"100% of the restricted stock units vest on the one-year anniversary of the grant date. Vested shares will be delivered to the reporting person on the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"100% of the restricted stock units vest on the one-year anniversary of the grant date. Vested shares will be delivered to the reporting person on the vesting date."}],"balance_after":1500,"derivative":{"underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001609351-18-000054","document":"wf-form4_152781652931863.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000160935118000054/wf-form4_152781652931863.xml","form_type":"4"}},{"id":3912399,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-01T01:29:03.000Z","date":"2018-05-30","kind":"grant","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares vest on the one-year anniversary of the grant date."}],"balance_after":4000,"derivative":{"exercise_price":81.53,"expiration_date":"2028-05-29","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001609351-18-000054","document":"wf-form4_152781652931863.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000160935118000054/wf-form4_152781652931863.xml","form_type":"4"}},{"id":3912398,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-01T01:29:03.000Z","date":"2018-05-31","kind":"exercise","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit converted into one share of Spark Therapeutics, Inc. common stock."}],"balance_after":26500,"source":{"system":"sec-edgar","filing":"0001609351-18-000054","document":"wf-form4_152781652931863.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000160935118000054/wf-form4_152781652931863.xml","form_type":"4"}},{"id":3971279,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-04T20:25:12.000Z","date":"2018-04-02","kind":"grant","acquired":true,"shares":295,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":19139,"source":{"system":"sec-edgar","filing":"0001209191-18-023643","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919118023643/doc4.xml","form_type":"4"}},{"id":4109566,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-04T21:15:05.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":18844,"source":{"system":"sec-edgar","filing":"0001209191-18-001916","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919118001916/doc4.xml","form_type":"4"}},{"id":4193234,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-04T20:45:48.000Z","date":"2017-10-02","kind":"grant","acquired":true,"shares":435,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":18454,"source":{"system":"sec-edgar","filing":"0001209191-17-055896","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919117055896/doc4.xml","form_type":"4"}},{"id":4262920,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-06T20:03:14.000Z","date":"2017-07-03","kind":"grant","acquired":true,"shares":569,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":18019,"source":{"system":"sec-edgar","filing":"0001209191-17-043966","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919117043966/doc4.xml","form_type":"4"}},{"id":4280802,"issuer":{"id":17020,"kind":"organization","name":"Mead Johnson Nutrition Co","symbol":"MJN"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-06-15T19:42:21.000Z","date":"2017-06-15","kind":"disposition_to_issuer","acquired":false,"shares":1709,"price":90,"value":153810.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This RSU was originally scheduled to vest on February 28, 2018. Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person vested and were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the number of shares of common stock subject to such RSU immediately prior to the effective time of the merger and (ii) $90.00 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This RSU was originally scheduled to vest on February 28, 2018. Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person vested and were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the number of shares of common stock subject to such RSU immediately prior to the effective time of the merger and (ii) $90.00 per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This RSU was originally scheduled to vest on February 28, 2018. Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person vested and were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the number of shares of common stock subject to such RSU immediately prior to the effective time of the merger and (ii) $90.00 per share."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1709},"source":{"system":"sec-edgar","filing":"0001104659-17-039505","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000110465917039505/a4.xml","form_type":"4"}},{"id":4280801,"issuer":{"id":17020,"kind":"organization","name":"Mead Johnson Nutrition Co","symbol":"MJN"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-15T19:42:21.000Z","date":"2017-06-15","kind":"disposition_to_issuer","acquired":false,"shares":16792.3848,"price":90,"value":1511314.632,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated February 10, 2017, by and among Mead Johnson Nutrition Company (\"MJN\"), Reckitt Benckiser Group plc, and Marigold Merger Sub, Inc. (the \"Merger Agreement\"), at the effective time of the merger, each share of MJN common stock held by the reporting person was converted into the right to receive a cash payment equal to $90.00 per share."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-17-039505","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000110465917039505/a4.xml","form_type":"4"}},{"id":4295713,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-06-02T20:04:52.000Z","date":"2017-05-31","kind":"grant","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Spark Therapeutics, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the restricted stock units vest on the one-year anniversary of the grant date.  Vested shares will be delivered to the reporting person on the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"100% of the restricted stock units vest on the one-year anniversary of the grant date.  Vested shares will be delivered to the reporting person on the vesting date."}],"balance_after":1500,"derivative":{"underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001609351-17-000045","document":"wf-form4_149643387416366.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000160935117000045/wf-form4_149643387416366.xml","form_type":"4"}},{"id":4295712,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-02T20:04:52.000Z","date":"2017-05-31","kind":"grant","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares vest on the one-year anniversary of the grant date."}],"balance_after":4000,"derivative":{"exercise_price":50.93,"expiration_date":"2027-05-30","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001609351-17-000045","document":"wf-form4_149643387416366.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000160935117000045/wf-form4_149643387416366.xml","form_type":"4"}},{"id":4359394,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-05T20:08:09.000Z","date":"2017-04-03","kind":"grant","acquired":true,"shares":1216,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":17450,"source":{"system":"sec-edgar","filing":"0001209191-17-025582","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919117025582/doc4.xml","form_type":"4"}},{"id":4409375,"issuer":{"id":17020,"kind":"organization","name":"Mead Johnson Nutrition Co","symbol":"MJN"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit (RSU)","published_at":"2017-03-02T15:02:26.000Z","date":"2017-03-01","kind":"exercise","acquired":false,"shares":2373,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the contingent right to receive one share of common stock.  This transaction represents the settlement of vested restricted stock units in shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities."}],"balance_after":0,"derivative":{"exercise_date":"2017-03-01","expiration_date":"2017-03-01","underlying":"Common Stock","underlying_shares":2373},"source":{"system":"sec-edgar","filing":"0001209191-17-016251","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000120919117016251/doc4.xml","form_type":"4"}},{"id":4409374,"issuer":{"id":17020,"kind":"organization","name":"Mead Johnson Nutrition Co","symbol":"MJN"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit (RSU)","published_at":"2017-03-02T15:02:26.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":1709,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities."}],"balance_after":1709,"derivative":{"exercise_date":"2018-02-28","expiration_date":"2018-02-28","underlying":"Common Stock","underlying_shares":1709},"source":{"system":"sec-edgar","filing":"0001209191-17-016251","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000120919117016251/doc4.xml","form_type":"4"}},{"id":4409373,"issuer":{"id":17020,"kind":"organization","name":"Mead Johnson Nutrition Co","symbol":"MJN"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-02T15:02:26.000Z","date":"2017-03-01","kind":"exercise","acquired":true,"shares":2373,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16792.3848,"source":{"system":"sec-edgar","filing":"0001209191-17-016251","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1458116/000120919117016251/doc4.xml","form_type":"4"}},{"id":4500586,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-05T21:12:54.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":804,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":16234,"source":{"system":"sec-edgar","filing":"0001209191-17-002002","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919117002002/doc4.xml","form_type":"4"}},{"id":4518002,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-19T21:06:01.000Z","date":"2016-12-15","kind":"grant","acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":15430,"source":{"system":"sec-edgar","filing":"0001209191-16-155874","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919116155874/doc4.xml","form_type":"4"}},{"id":4585644,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":34802,"kind":"person","name":"Altschuler Steven","position":1,"cik":"0001458116","reported_name":"Altschuler Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-05T20:13:43.000Z","date":"2016-10-03","kind":"grant","acquired":true,"shares":904,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":14430,"source":{"system":"sec-edgar","filing":"0001209191-16-144888","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919116144888/doc4.xml","form_type":"4"}}]}